Biopsy Forceps Market Size, Share, Growth, and Industry Analysis, By Type (Rigid biopsy forceps, Flexible biopsy forceps), By Application (Laparoscopy, Endoscopy detect for respiratory tract, Endoscopy detect for digestive tract, Other), Regional Insights and Forecast to 2035

Biopsy Forceps Market Overview

The global Biopsy Forceps Market size estimated at USD 283.07 million in 2026 and is projected to reach USD 372.25 million by 2035, growing at a CAGR of 3.09% from 2026 to 2035.

The Biopsy Forceps Market is expanding due to increasing diagnostic procedures, rising prevalence of chronic diseases, and growing adoption of minimally invasive medical techniques. Biopsy forceps are specialized surgical instruments used for tissue sampling during endoscopic and laparoscopic procedures. In 2025, more than 1 billion endoscopic procedures are performed globally each year, creating strong demand for precision biopsy instruments. The market is influenced by advancements in flexible endoscopy, improved tissue acquisition technologies, and increasing healthcare infrastructure development. Disposable biopsy forceps are gaining preference, with hospitals increasingly adopting single-use instruments to reduce infection risks and improve procedural safety. The market includes rigid and flexible biopsy forceps used across gastroenterology, pulmonology, urology, and surgical applications.

The USA biopsy forceps market is supported by advanced healthcare facilities, high adoption of minimally invasive diagnostics, and increasing gastrointestinal disease screening programs. The country performs more than 20 million gastrointestinal endoscopic procedures annually, generating significant demand for biopsy forceps. Around 60% of adults aged above 50 years in the USA undergo colorectal cancer screening according to recommended medical guidelines, increasing tissue sampling requirements. Hospitals and ambulatory surgical centers are adopting disposable biopsy forceps due to infection control standards. The presence of advanced endoscopy centers, skilled physicians, and continuous development of surgical technologies strengthens the USA market position.

Key Findings

• Key Market Driver: Rising endoscopy procedures and minimally invasive diagnosis increase biopsy forceps demand by 65%.
• Major Market Restraint: High equipment costs and sterilization requirements create 35% purchasing challenges.
• Emerging Trends: Disposable biopsy forceps adoption reaches 45% due to infection control needs.
• Regional Leadership: North America leads with nearly 40% market utilization.
• Competitive Landscape: Leading manufacturers control approximately 55% market share through advanced technologies.
• Market Segmentation: Flexible biopsy forceps dominate with 60% demand, while rigid types hold 40%.
• Recent Development: Product innovation increased by 30% from 2023 to 2025, focusing on disposable and precision designs.

Biopsy Forceps Market Latest Trends

The Biopsy Forceps Market is experiencing significant transformation due to technological improvements and increasing demand for accurate diagnostic procedures. Flexible biopsy forceps are becoming more popular, representing nearly 60% of overall usage because they provide improved access during complex endoscopic procedures. Disposable biopsy forceps are gaining attention, with approximately 45% of healthcare facilities preferring single-use devices to minimize infection risks and eliminate sterilization challenges.

Healthcare providers are also shifting toward cost-effective disposable instruments due to strict infection control requirements. Approximately 70% of hospitals prioritize contamination prevention measures when selecting surgical instruments. Emerging markets are increasing investments in diagnostic infrastructure, further supporting biopsy forceps adoption across hospitals, specialty clinics, and outpatient centers.

Biopsy Forceps Market Dynamics

DRIVER

" Rising demand for minimally invasive diagnostic procedures."

The growing adoption of endoscopic and laparoscopic techniques is a primary driver of the biopsy forceps market. More than 80% of gastrointestinal diagnostic procedures now involve minimally invasive approaches, increasing the requirement for flexible and precise biopsy instruments. Hospitals prefer biopsy forceps because they allow accurate tissue collection without major surgical intervention. Increasing awareness regarding early disease detection has also improved screening participation rates. Colorectal cancer screening programs, respiratory disease evaluations, and digestive disorder diagnosis procedures are increasing globally.

RESTRAINT

" High costs associated with advanced biopsy instruments and maintenance."

The cost factor remains a significant challenge, especially in developing healthcare markets where approximately 40% of medical facilities operate under strict equipment purchasing limitations. Advanced biopsy forceps require high-quality materials, precision manufacturing, and regulatory compliance, increasing overall procurement expenses. Reusable biopsy forceps also require proper cleaning and sterilization procedures, adding operational costs for healthcare providers. Small hospitals and diagnostic centers may experience difficulties adopting premium biopsy devices due to budget constraints.

OPPORTUNITY

" Expansion of disposable biopsy forceps adoption in emerging healthcare markets."

The increasing preference for single-use medical instruments creates strong opportunities for biopsy forceps manufacturers. Disposable biopsy forceps usage has increased by approximately 45% due to rising awareness about infection prevention and hospital safety standards. Emerging economies are improving healthcare infrastructure, with thousands of new hospitals and diagnostic centers being established annually. Growing medical tourism in countries with advanced healthcare services is also supporting demand for high-quality biopsy instruments. Manufacturers focusing on affordable disposable solutions, improved designs, and localized production strategies can capture additional market opportunities.

CHALLENGE

" Increasing regulatory requirements for medical device approval."

Biopsy forceps manufacturers face challenges due to strict quality standards and regulatory processes across different regions. Approximately 50% of medical device development activities require extensive testing related to safety, performance, and material compatibility. Compliance with sterilization standards, biocompatibility requirements, and manufacturing controls increases product development complexity. Companies must continuously invest in research and quality management systems to maintain approvals. Competition from low-cost manufacturers also creates pricing pressure in several markets. Healthcare providers increasingly demand reliable products with proven performance, making quality assurance a critical factor.

Biopsy Forceps Market Segmentation

By Type

Rigid Biopsy Forceps: Rigid biopsy forceps are specialized instruments mainly used in surgical procedures requiring direct access to targeted tissues. These devices account for approximately 40% of the biopsy forceps market due to their application in laparoscopic surgeries, urological procedures, and specialized tissue extraction. Rigid biopsy forceps provide strong mechanical control, enhanced gripping ability, and accurate specimen collection. They are commonly manufactured using stainless steel materials that support durability and repeated sterilization cycles. Around 60% of reusable biopsy forceps used in surgical environments are designed with rigid structures because they provide better handling during complex procedures. Hospitals prefer rigid biopsy forceps for procedures requiring higher mechanical strength and precise tissue manipulation. Advancements in minimally invasive surgery have increased demand for improved rigid forceps designs with ergonomic handles and enhanced jaw mechanisms.

Flexible Biopsy Forceps: Flexible biopsy forceps represent the largest product category, accounting for nearly 60% of market usage due to their widespread application in endoscopic diagnosis. These instruments are designed with flexible shafts that allow physicians to access difficult anatomical locations during gastrointestinal and respiratory procedures. More than 70% of upper gastrointestinal endoscopy procedures require tissue sampling capabilities, supporting strong demand for flexible biopsy forceps. Disposable flexible biopsy forceps are increasingly preferred, representing approximately 45% of new purchases because they reduce contamination risks and eliminate complex sterilization requirements. Manufacturers are developing advanced flexible forceps with sharper jaws, improved opening angles, and enhanced tissue capture performance.

BY APPLICATION

Laparoscopy: Laparoscopy represents an important application segment of the biopsy forceps market, contributing approximately 20% of overall demand. These instruments are used during minimally invasive abdominal and pelvic procedures where surgeons require accurate tissue samples. The increasing adoption of laparoscopic surgeries has supported demand for specialized biopsy devices with improved precision and maneuverability. More than 15 million laparoscopic procedures are performed globally each year, creating continuous requirements for biopsy forceps. Rigid biopsy forceps are commonly used in laparoscopic applications because they provide enhanced control during tissue collection. Hospitals are increasingly investing in advanced laparoscopic equipment due to reduced recovery times and lower surgical complications.

Endoscopy Detect for Respiratory Tract: Respiratory tract endoscopy applications contribute nearly 25% of biopsy forceps demand due to increasing diagnosis of lung diseases and respiratory abnormalities. Bronchoscopy procedures frequently require biopsy forceps for collecting tissue samples from airway structures. More than 2 million bronchoscopies are performed annually in major healthcare systems, supporting demand for specialized respiratory biopsy instruments. Flexible biopsy forceps dominate this segment because they provide improved navigation through complex airway pathways. Rising cases of lung cancer, pulmonary infections, and chronic respiratory disorders are increasing diagnostic requirements. Advanced biopsy forceps with smaller diameters and improved flexibility are being developed to enhance sampling accuracy.

Endoscopy Detect for Digestive Tract: Digestive tract endoscopy is the leading application segment, accounting for approximately 50% of biopsy forceps usage globally. Gastrointestinal endoscopy procedures require biopsy forceps for diagnosing conditions such as colorectal cancer, inflammatory bowel disease, gastric disorders, and abnormal tissue growth. More than 20 million gastrointestinal endoscopy procedures are performed annually in the USA alone, demonstrating strong demand for biopsy instruments. Flexible biopsy forceps dominate this segment due to their compatibility with gastroscopy and colonoscopy procedures. Increasing colorectal cancer screening programs have significantly increased tissue sampling requirements. Hospitals and diagnostic centers are adopting disposable biopsy forceps to improve infection control, with approximately 45% of facilities preferring single-use options.

Other Applications: Other applications include urology, gynecology, ENT procedures, and specialized surgical interventions, collectively representing approximately 5% of biopsy forceps demand. These applications require customized biopsy instruments designed for specific anatomical conditions and procedural requirements. Increasing adoption of minimally invasive diagnostic techniques has created demand for smaller and more precise biopsy devices. ENT procedures involving nasal and throat tissue sampling are increasingly using specialized flexible forceps designs. Urology applications also utilize biopsy forceps for targeted tissue collection during diagnostic procedures. Manufacturers are developing application-specific instruments with improved control features and enhanced durability.

Biopsy Forceps Market Regional Outlook

NORTH AMERICA

North America represents the largest regional market for biopsy forceps, accounting for approximately 40% of global usage. The region benefits from advanced healthcare infrastructure, high adoption of minimally invasive procedures, and strong demand for diagnostic technologies. The USA contributes the majority of regional demand due to performing more than 20 million gastrointestinal endoscopy procedures annually. Increasing colorectal cancer screening initiatives have significantly increased biopsy requirements, with millions of tissue samples collected each year for diagnostic evaluation.

Hospitals and ambulatory surgical centers in North America are increasingly adopting disposable biopsy forceps, with approximately 45% of healthcare facilities preferring single-use instruments to improve infection control. The presence of leading medical device manufacturers and advanced research facilities supports continuous product innovation. Flexible biopsy forceps dominate regional demand because of their extensive use in gastroenterology and respiratory diagnostics. Canada also contributes to regional growth through investments in healthcare modernization and minimally invasive surgery adoption.

EUROPE

Europe holds approximately 30% of the global biopsy forceps market due to strong healthcare systems, advanced diagnostic infrastructure, and widespread adoption of endoscopic procedures. Countries including Germany, the United Kingdom, France, and Italy represent major contributors because of established medical device industries and high procedure volumes. More than 10 million gastrointestinal endoscopy procedures are conducted annually across European healthcare systems, supporting consistent demand for biopsy instruments.

European manufacturers continue investing in precision engineering, ergonomic designs, and advanced materials for biopsy forceps production. Strict medical device regulations encourage innovation and quality improvements. Aging populations across European countries are increasing demand for diagnostic procedures, as individuals above 65 years represent a significant portion of healthcare users. Growth in outpatient diagnostic centers and minimally invasive surgery adoption further supports regional market expansion.

ASIA-PACIFIC

Asia-Pacific represents approximately 25% of the biopsy forceps market and is one of the fastest developing regions due to expanding healthcare access and increasing diagnostic awareness. Countries such as China, Japan, India, and South Korea are increasing investments in hospitals, medical technology, and specialized diagnostic centers. More than 60% of new healthcare infrastructure projects in developing Asian economies include advanced diagnostic equipment requirements.

Healthcare modernization programs are improving access to advanced diagnostic technologies, especially in urban areas. Approximately 50% of hospitals in major Asian cities now utilize advanced endoscopic equipment, supporting biopsy instrument demand. Local manufacturers are focusing on affordable biopsy solutions to meet growing healthcare needs. Increasing medical tourism in countries such as India and Thailand also supports adoption of advanced biopsy devices.

MIDDLE EAST & AFRICA

The Middle East & Africa region accounts for approximately 5% of the global biopsy forceps market but demonstrates increasing adoption due to healthcare development initiatives. Countries such as Saudi Arabia, United Arab Emirates, and South Africa are investing in modern hospitals and diagnostic centers. Healthcare infrastructure expansion has increased demand for advanced biopsy instruments.

Government healthcare investments and partnerships with international medical device companies are improving availability of surgical instruments. Flexible biopsy forceps are gaining popularity due to increased adoption of gastrointestinal and respiratory diagnostic procedures. As healthcare systems continue to modernize, demand for reliable biopsy instruments is expected to increase across the region.

List of Top Biopsy Forceps Companies

• Olympus Corporation
• Boston Scientific Corporation
• Karl Storz
• Cook Medical
• HOYA Corporation (PENTAX Medical)
• Argon Medical Devices
• CONMED Corporation
• Fujifilm Holdings Corporation
• Cordis (Johnson & Johnson medical device business)
• Micro Tech
• Wilson
• Alton
• Tiansong
• Jiuhong
• Jingrui
• Stryker Corporation
• Richard Wolf GmbH
• Rudolf Medical
• Aesculap AG
• SMEW
• Xinhua
• Tonglu
• Guangdian
• Shenda
• Kangji Medical
• Jin Baolong

Top Two Companies Market Share

• Olympus Corporation holds approximately 20% share
• Boston Scientific Corporation accounts for nearly 15% market share

Investment Analysis and Opportunities

The Biopsy Forceps Market presents investment opportunities due to increasing demand for diagnostic procedures, expansion of minimally invasive surgeries, and rising adoption of disposable medical instruments. Healthcare facilities are increasing investments in endoscopy technologies, with more than 70% of advanced hospitals prioritizing modern diagnostic equipment to improve patient outcomes. Investment opportunities are particularly strong in disposable biopsy forceps manufacturing because approximately 45% of healthcare providers prefer single-use instruments for infection prevention.

Companies focusing on advanced materials, ergonomic designs, and precision manufacturing can capture growing demand from hospitals and specialty clinics. Emerging economies are creating additional opportunities as healthcare infrastructure expands, with thousands of new diagnostic centers being developed in Asia-Pacific and Middle Eastern markets. Manufacturers investing in affordable biopsy solutions can address the requirements of cost-sensitive healthcare systems.

Research and development activities are increasing toward smaller, flexible, and highly accurate biopsy forceps. Approximately 30% of recent product innovations focus on improving tissue acquisition efficiency, reducing procedural time, and enhancing physician control. Partnerships between medical device companies and healthcare institutions are also increasing to develop procedure-specific biopsy instruments.

The growing use of artificial intelligence-assisted endoscopy systems creates opportunities for integrated biopsy solutions. Companies developing compatible instruments for advanced imaging platforms can strengthen their competitive position. Investments in regulatory compliance, manufacturing automation, and global distribution networks remain important strategies for long-term market participation.

New Product Development

New product development in the Biopsy Forceps Market is focused on improving accuracy, safety, flexibility, and procedural efficiency. Manufacturers are introducing advanced disposable biopsy forceps with improved jaw mechanisms, enhanced shaft flexibility, and optimized designs for different endoscopic applications. Approximately 45% of newly developed biopsy instruments emphasize single-use technology to reduce infection risks and simplify hospital workflows.

Advanced material development is becoming an important focus area, with companies using high-strength stainless steel alloys and lightweight components to improve instrument durability. More than 30% of product improvements are related to better tissue capture performance, ergonomic handles, and physician comfort. These innovations help healthcare professionals collect higher-quality samples during diagnostic procedures.

Manufacturers are also developing miniature biopsy forceps designed for specialized applications such as pediatric endoscopy and narrow anatomical pathways. Smaller instrument designs improve accessibility and reduce procedural complications. Integration with advanced endoscopy platforms is another growing development area, allowing better compatibility with modern diagnostic systems.

Digital healthcare advancements are influencing product design strategies, with companies exploring biopsy instruments that support improved procedural monitoring and documentation. The demand for customized solutions is increasing as hospitals seek instruments optimized for specific procedures. Between 2023 and 2025, manufacturers increased focus on disposable technologies, advanced coatings, and precision engineering to improve biopsy forceps performance.

Five Recent Developments (2023-2025)

• Olympus Corporation expanded its endoscopy accessory portfolio in 2023 by improving biopsy instrument designs focused on enhanced tissue collection efficiency and compatibility with advanced gastrointestinal procedures.
• Boston Scientific Corporation introduced improvements in endoscopic accessory technologies during 2024, focusing on precision biopsy solutions and improved procedural workflow efficiency.
• Fujifilm Holdings Corporation strengthened its endoscopy product development activities in 2024 by improving diagnostic accessory technologies supporting gastrointestinal and respiratory applications.
• CONMED Corporation expanded minimally invasive surgical product innovations in 2025, focusing on improved instrument handling and procedural accuracy.
• Karl Storz continued development of advanced endoscopic instruments in 2025, supporting improved biopsy procedures through enhanced visualization and accessory compatibility.

Report Coverage of Biopsy Forceps Market

The Biopsy Forceps Market report provides comprehensive analysis covering product types, applications, regional performance, competitive landscape, and emerging industry trends. The study evaluates rigid and flexible biopsy forceps segments, which represent approximately 40% and 60% of market usage respectively. The report analyzes applications including laparoscopy, respiratory tract endoscopy, digestive tract endoscopy, and other specialized procedures.

The report covers regional analysis across North America, Europe, Asia-Pacific, and the Middle East & Africa, highlighting healthcare infrastructure, procedure volumes, and adoption patterns. North America represents approximately 40% market share, while Europe contributes nearly 30% and Asia-Pacific accounts for approximately 25%.

The competitive assessment includes more than 25 major manufacturers involved in biopsy forceps production, technology development, and global distribution. The analysis reviews product innovation strategies, manufacturing capabilities, and market positioning of leading companies.

The report also examines market drivers, restraints, opportunities, and challenges influencing industry development. Key focus areas include increasing minimally invasive procedures, rising disposable instrument adoption, regulatory requirements, and technological advancements. Product innovation analysis covers developments from 2023 to 2025, including improvements in flexibility, precision, and infection control features. The report provides valuable insights for medical device companies, investors, healthcare providers, and industry stakeholders evaluating opportunities in the biopsy forceps market.